OBJECTIVE: The purpose of this study was to evaluate the cytogenetic and fluorescent in situ hybridization (FISH) profile in children with acute lymphoblastic leukemia (ALL), referred to a university hospital in a 5-year 6-month period. SUBJECTS AND METHODS: Cytogenetic analysis of the bone marrow aspirate specimens of 91 patients was performed by standard Giemsa (G)-banding and interphase FISH (iFISH). RESULTS: The frequency of chromosomal abnormalities detected by G-banding was 29.5%, and the frequency of nonrandom abnormalities with independent prognostic significance identified by iFISH was 46.4%. The abnormality with the highest frequency was gain of RUNX1 (n = 18, 21.4%), followed by ETV6/RUNX1 fusion (n = 7, 8.3%), and gain of KMT2A (n = 6, 7.1%). Additionally, rarely reported gains of ETV6, PBX1, and ABL1 were observed at a frequency of 6% (n = 5), and the deletion of ETV6 and TCF3 was seen at a frequency of 3.6% (n = 3) and 2.3% (n = 2), respectively. A 10-year old with intrachromosomal amplification of chromosome 21 was also observed. CONCLUSIONS: This study strengthens and widens the current knowledge of the cytogenetic landscape of pediatric ALL.
OBJECTIVE: The purpose of this study was to evaluate the cytogenetic and fluorescent in situ hybridization (FISH) profile in children with acute lymphoblastic leukemia (ALL), referred to a university hospital in a 5-year 6-month period. SUBJECTS AND METHODS: Cytogenetic analysis of the bone marrow aspirate specimens of 91 patients was performed by standard Giemsa (G)-banding and interphase FISH (iFISH). RESULTS: The frequency of chromosomal abnormalities detected by G-banding was 29.5%, and the frequency of nonrandom abnormalities with independent prognostic significance identified by iFISH was 46.4%. The abnormality with the highest frequency was gain of RUNX1 (n = 18, 21.4%), followed by ETV6/RUNX1 fusion (n = 7, 8.3%), and gain of KMT2A (n = 6, 7.1%). Additionally, rarely reported gains of ETV6, PBX1, and ABL1 were observed at a frequency of 6% (n = 5), and the deletion of ETV6 and TCF3 was seen at a frequency of 3.6% (n = 3) and 2.3% (n = 2), respectively. A 10-year old with intrachromosomal amplification of chromosome 21 was also observed. CONCLUSIONS: This study strengthens and widens the current knowledge of the cytogenetic landscape of pediatric ALL.
Authors: Anthony V Moorman; Hannah M Ensor; Sue M Richards; Lucy Chilton; Claire Schwab; Sally E Kinsey; Ajay Vora; Chris D Mitchell; Christine J Harrison Journal: Lancet Oncol Date: 2010-04-19 Impact factor: 41.316
Authors: F M Mikhail; K A Serry; N Hatem; Z I Mourad; H M Farawela; D M El Kaffash; L Coignet; G Nucifora Journal: Leukemia Date: 2002-04 Impact factor: 11.528
Authors: Christine J Harrison; Anthony V Moorman; Kerry E Barber; Zoë J Broadfield; Kan L Cheung; Rachel L Harris; G Reza Jalali; Hazel M Robinson; Jonathan C Strefford; Adam Stewart; Sarah Wright; Mike Griffiths; Fiona M Ross; Louise Harewood; Mary Martineau Journal: Br J Haematol Date: 2005-05 Impact factor: 6.998
Authors: James T Mascarello; Betsy Hirsch; Hutton M Kearney; Rhett P Ketterling; Susan B Olson; Denise I Quigley; Kathleen W Rao; James H Tepperberg; Karen D Tsuchiya; Anne E Wiktor Journal: Genet Med Date: 2011-07 Impact factor: 8.822